MedTrace Logo

Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV

NCT00575757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2016-08-18

No results posted yet for this study

Summary

Because NASH is now recognized as a significant cause of cirrhosis with associated morbidity and mortality, its recognition as a long term complication of HAART is important to the management of those living with HIV.

Conditions

  • Steatohepatitis

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Richard K Sterling, MD MSc · VCU

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575757 on ClinicalTrials.gov